Evidence map›Paper›PMID 24074563›Full record

ArticleVirology2013

An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes.

Mei Xu, Rachel A Katzenellenbogen, Carla Grandori, Denise A Galloway

Open access · greenAbstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E.Endocrinology and metabolism (Seoul, Korea) · 2020
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mei XuDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA 98195, USA.
Rachel A Katzenellenbogen
Carla Grandori
Denise A Galloway
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

INTERACTIONS OF HPV ONCOGENES WITH THE P53 PATHWAYR01CA064795 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GALLOWAY, DENISE A. · 1995 to 2017
$8.6M
Regulation of Telomerase by NFX1K08CA131171 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI KATZENELLENBOGEN, RACHEL ADRIA · 2008 to 2012
$672k
NCI NIH HHS K08 CA131171NCI NIH HHS K08CA131171NCI NIH HHS R01 CA064795NCI NIH HHS R01CA064795
6 · The paper itself

Abstract

Activation of telomerase by human papillomavirus 16 (HPV16) E6 is a critical step for cell immortalization and transformation in human foreskin keratinocytes (HFKs). Multiple transcription factors have been identified as being involved in E6-induced hTERT expression. Here, we adapted an unbiased in vivo screen using a LacO-LacI system in human cells to discover hTERT promoter-interacting regulators. This approach allowed us to identify a novel hTERT repressor, Maz, which bound the hTERT promoter. E6 expression reduced Maz binding and correspondingly increased Sp1 binding at the hTERT promoter. Knockdown of Maz further increased histone acetylation, as well as hTERT expression in the presence of E6. Overall, these data indicate the utility of a novel screen for promoter-interacting and transcription-regulating proteins. These data also highlight multiple factors that normally regulate hTERT repression in HFKs, and therefore are targeted by E6 for hTERT expression.

Indexed as

Cell Transformation, ViralHost-Pathogen Interactionsbeta-GalactosidaseGene Expression RegulationGenes, ReporterHuman papillomavirus 16HumansKeratinocytesOncogene Proteins, ViralPromoter Regions, GeneticRepressor ProteinsTelomeraseTranscription FactorsTranscription, Geneticbeta-GalactosidaseE6 protein, Human papillomavirus type 16Oncogene Proteins, ViralRepressor ProteinsTelomeraseTERT protein, humanTranscription FactorsHPV E6hTERTKeratinocytesMazSp1

Identifiers

PMID24074563
PMCPMC3787310
OpenAlexW2086704374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.